Clinical Interests

Research Interests

Clinical Trials

"Use of HypoMap to Reduce Hypoglycemic Events in Type 1 Diabetes" a pilot study to determine if the use of a new Smartphone App called "HypoMap" can improve hypoglycemic awareness and reduce serious hypoglycemic events/time in hypoglycemia in Adults with Type 1 Diabetes (T1D). Read more

A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon) on Glucose
Control in Patients with Type 1 Diabetes. Read more

A Randomized, Multicenter Study to Evaluate Cardiovascular Outcomes with ITCA 650 in Patients Treated with Standard of Care for Type 2 Diabetes Read more

ADJUNCTONETM: The efficacy and safety of liraglutide as adjunct therapy to insulin in the treatment of type 1 diabetes Read more

Web Resources

Publications

Link to PubMed (Opens new window. Close the PubMed window to return to this page.)

Research Abstract

Our research focuses on the study of new approaches for the prevention and management of diabetes mellitus and its complications. Current projects include: (1) A 5 year randomized controlled trial of 2 active telephone-based treatment interventions, based on the Diabetes Prevention Program model, that are delivered at primary care practices, with the primary outcome of weight loss. (2) The study of the use of telemedicine to improve care and the delivery of health care services to people with diabetes. (3) Participation in the TODAY study (Treatment Options for Type 2 Diabetes in Adolescents and Youth), a nationwide trial examining different ways of treating 10-17 year olds with type 2 diabetes. (4) Investigations of the effectiveness and safety of new therapeutic agents for the prevention and treatment of diabetes mellitus.